Beijing-based CapitalBio nets over $113m ahead of STAR Market IPO

Beijing-based CapitalBio nets over $113m ahead of STAR Market IPO

Chinese life science solutions provider CapitalBio Technology has secured over 800 million yuan ($113 million) in financing ahead of a planned initial public offering (IPO) on the country’s Nasdaq-style STAR Market.

The investment will help CapitalBio “further consolidate a leading position in the genetic testing and biochip areas,” ahead of a planned shareholding restructuring and an application for an IPO on Shanghai’s STAR Market, said the company in a statement on late Thursday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter